Page last updated: 2024-10-24

verapamil and HIV

verapamil has been researched along with HIV in 2 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Speck, RR1
Yu, XF1
Hildreth, J1
Flexner, C1
Chandler, B1
Detsika, M1
Owen, A1
Evans, S1
Hartkoorn, RC1
Cane, PA1
Back, DJ1
Khoo, SH1

Other Studies

2 other studies available for verapamil and HIV

ArticleYear
Differential effects of p-glycoprotein and multidrug resistance protein-1 on productive human immunodeficiency virus infection.
    The Journal of infectious diseases, 2002, Aug-01, Volume: 186, Issue:3

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Cells, Cultured;

2002
Effect of transporter modulation on the emergence of nelfinavir resistance in vitro.
    Antiviral therapy, 2007, Volume: 12, Issue:5

    Topics: Cell Line; Cytopathogenic Effect, Viral; DNA Mutational Analysis; Drug Resistance, Viral; HIV; HIV P

2007